Results 141 to 150 of about 5,298,587 (157)

Fibroblast Activation Targeted Imaging Identifies Coronary Restenosis. [PDF]

Clin Nucl Med
Xi XY, Yang S, Tu B, Zhao L, Yang MF.
europepmc   +1 more source

Comparative Performance of ⁶⁸ Ga-FAPI-04 and ¹⁸ F-FDG PET/CT in Ovarian Cancer: Focus on Peritoneal Carcinomatosis. [PDF]

World J Nucl Med
Arslan E, Alçin G, Ergül N, Akgün E, Şahin ÖF, Tosunoğlu Z, Öztürk AE, Çermik TF.   +7 more
europepmc   +1 more source

Application of theranostics in thyroid cancer management.

J Clin Endocrinol Metab
Sridhar A, Behiri N, Klubo-Gwiezdzinska J.   +2 more
europepmc   +1 more source

Highlighting Fibroblasts Activation in Fibrosis: The State-of-the-Art Fibroblast Activation Protein Inhibitor PET Imaging in Cardiovascular Diseases

Journal of Clinical Medicine, 2023
Fibrosis is a common healing process that occurs during stress and injury in cardiovascular diseases. The evolution of fibrosis is associated with cardiovascular disease states and causes adverse effects.
Bulin Du, Shu Wang
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

The Clinical Landscape of HDAC Inhibitors

Medical Epigenetics, 2021
Arasu Ganesan
exaly  

Fibroblast Activation Protein Inhibitor (FAPi) Positive Tumour Fraction on PET/CT Correlates With Ki-67 in Liver Metastases of Neuroendocrine Tumours

Nuklearmedizin - NuclearMedicine, 2021
Frank Rösch, Georg Feldmann, Euy Sung Moon   +2 more
exaly  

Head-to-Head Comparison of Fibroblast Activation Protein Inhibitors (FAPI) Radiotracers Versus [18F]F-FDG in Oncology: A Systematic Review

International Journal of Molecular Sciences, 2021
Giorgio Treglia, Ramin Sadeghi, Barbara Muoio   +2 more
exaly  

Fibroblast Activation Protein Targeted Therapy Using [177Lu]FAPI-46 Compared With [225Ac]FAPI-46 in a Pancreatic Cancer Model

European Journal of Nuclear Medicine and Molecular Imaging, 2022
Tadashi Watabe, Kazuhiro Ooe, Frederik Giesel   +2 more
exaly  

Fibroblast Activation Protein Inhibitor (FAPI)-PET Imaging in Sarcoma

PET Clinics, 2023
Lukas Kessler
exaly  

Radiolabeled Fibroblast Activation Protein Inhibitor (FAPI) PET in Oncology: Has the Time Come for 18F-Fluorodeoxyglucose to Think to a Well-Deserved Retirement?

Clinical and Translational Imaging, 2021
Priscilla Guglielmo, Luca Guerra
exaly